| Literature DB >> 26507783 |
Abstract
The ocular side effects of systemic treatments are numerous and sometimes severe. The prescriber and the ophthalmologist should be aware of ocular side effects of systemic treatments in order to inform their patients accordingly, implement appropriate ophthalmological monitoring and/or treatment and if necessary, adapt the therapeutic management. In this review, we describe the recently recognized ophthalmic complications of systemic treatments, except for optic neuropathies.Entities:
Keywords: Biphosphonate; Bisphosphonate; Cancer target therapy; Effets indésirables oculaires; Etanercept; Fingolimod; Inhibiteurs de la phosphodiestérase; Interféron; Nicorandil; Ocular adverse effects; Phosphodiesterase inhibitors; Thérapies ciblées anticancéreuses; Topiramate; Étanercept
Mesh：
Substances：
Year: 2015 PMID： 26507783 DOI： 10.1016/j.jfo.2015.05.004
Source DB: PubMed Journal: J Fr Ophtalmol ISSN： 0181-5512 Impact factor: 0.818